Hypertension Lipid Insights

Evolucumab in high-risk ‘primary prevention’

Lay Summary A large clinical trial called VESALIUS-CV tested whether the cholesterol-lowering drug evolocumab could prevent…
Olezarsen: A new option for severe hypertriglyceridemia

Lay Summary People with severely high triglycerides—blood fats at 500 mg/dL or more—face a serious risk…
Baxdrostat: new drug for hypertension

Lay Summary This study tested a new drug called baxdrostat to help people with high blood…

Evolucumab in high-risk ‘primary prevention’